Synonyms: CHI-621 | L04AC02 | SDZ-CHI-621 | Simulect®
basiliximab is an approved drug (FDA (1998), EMA (1998))
Compound class:
Antibody
Comment: Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
![]() View more information in the IUPHAR Pharmacology Education Project: basiliximab |
Classification ![]() |
|
Compound class | Antibody |
Approved drug? | Yes. FDA (1998) | EMA (1998) |
International Nonproprietary Names ![]() |
|
INN number | INN |
7578 | basiliximab |
Synonyms ![]() |
CHI-621 | L04AC02 | SDZ-CHI-621 | Simulect® |
Database Links ![]() |
|
Specialist databases | |
IMGT/mAb-DB | 148 |
Other databases | |
GtoPdb PubChem SID | 178103461 |
PubChem SID | 178103461 |
Search PubMed clinical trials | basiliximab |
Search PubMed titles | basiliximab |
Search PubMed titles/abstracts | basiliximab |
Wikipedia | Basiliximab |